Increasing Atrial Base Rate Pacing to Reduce Atrial Fibrillation
NCT ID: NCT02317068
Last Updated: 2015-10-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
200 participants
INTERVENTIONAL
2014-01-31
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reducing Atrial Pacing Rate to Reduce Atrial Fibrillation in Patients With Sick Sinus Syndrome.
NCT02034526
Pacing of the Atria in Sick Sinus Syndrome Trial Preventive Strategies for Atrial Fibrillation
NCT00161538
Pacing of Left Bundle Branch Area and Atroventricular Node ablatIon in Patients With Symptomatic Atrial Fibrillation
NCT06699342
Atrial Fibrillation With Sinus Node Dysfunction: Intensive Device Follow-up
NCT03607123
Atrial Pacing for Termination and Prevention of Atrial Fibrillation
NCT00123344
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High Atrial Base Rate Pacing
The base rate of pacemaker will be determined 75-100 beats/minute in condition that during first step of follow-up, his/her atrial pacing will be more than 80% of atrial high rate/automatic mode switch
HBR
Device Default
The base rate of pacemaker will be determined 60 beats/minute
DD
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HBR
DD
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having paroxysmal AF defined as at least 2 episodes of AHR/AMS \>190 b/min lasting \>6 minutes
* Having normal atrioventricular conduction
Exclusion Criteria
* History of acute coronary syndrome
* Significant heart valve disease
* Chronic AF before randomization
* Overt heart failure
* Malignancy
* Any reasons for antiarrhythmic medication use
* Inability to follow patients every 3 months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Urmia University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chancellor of research
Vice-Chancellor for Research in UMSU
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seyyed-al-Shohada Heart Center, UMSU
Urmia, West Azerbaijan Province, Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UMSU-Cardiology-4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.